Serum S100B and intelligence in children with Down syndrome

Background Down syndrome is characterized by physical and mental retardation and caused by chromosome 21 (Hsa21) abnormalities. The S100B is a protein that is overproduced in Down syndrome due to overexpression of chromosome 21 genes. Comorbidities caused by S100B in Down syndrome are cognitive dete...

Full description

Saved in:
Bibliographic Details
Main Authors: Nurul Noviarisa (Author), Eva Chundrayetti (Author), Gustina Lubis (Author)
Format: Book
Published: Indonesian Pediatric Society Publishing House, 2019-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9b0e4b59b8cf4fdc8072b908706c31db
042 |a dc 
100 1 0 |a Nurul Noviarisa  |e author 
700 1 0 |a Eva Chundrayetti  |e author 
700 1 0 |a Gustina Lubis  |e author 
245 0 0 |a Serum S100B and intelligence in children with Down syndrome 
260 |b Indonesian Pediatric Society Publishing House,   |c 2019-06-01T00:00:00Z. 
500 |a 0030-9311 
500 |a 2338-476X 
500 |a 10.14238/pi59.3.2019.125-9 
520 |a Background Down syndrome is characterized by physical and mental retardation and caused by chromosome 21 (Hsa21) abnormalities. The S100B is a protein that is overproduced in Down syndrome due to overexpression of chromosome 21 genes. Comorbidities caused by S100B in Down syndrome are cognitive deterioration and early onset of dementia. Objective To assess for a possible association between S100B protein and intelligence levels in children with Down syndrome. Method This cross-sectional study included students in a special needs school in Padang, West Sumatera, who had the characteristic clinical features of Down syndrome and trisomy 21 by chromosome analysis. Examination of S100B levels was carried out using an enzyme-linked immunosorbent assay (ELISA) method. Intelligence quotient (IQ) was measured using the 4th edition of the Wechlser Intelligence Scale for Children (WISC-IV) method. Results A total of 39 children with Down syndrome participated in the study. There were 25 children with mild mental retardation and 15 children with moderate-severe mental retardation. The mean S100B levels were not significantly different between groups [479.1 (SD 204) pg/mL in the mild mental retardation group and 458.7 (SD 158) pg/mL in the moderate-severe mental retardation group; P > 0.05]. The mean S100B level was significantly higher in subjects aged ≤ 10 years than in those aged > 10 years [566.9 (SD 210.0) pg/mL and 434.4 (SD 167.2) pg/mL, respectively (P<0.05)]. Conclusion There is no association between S100B and intelligence levels in children with Down syndrome. There is a significant association between higher S100B levels and younger age in children with Down syndrome. 
546 |a EN 
690 |a down syndrome 
690 |a s100b 
690 |a intelligence level 
690 |a Medicine 
690 |a R 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Paediatrica Indonesiana, Vol 59, Iss 3, Pp 125-9 (2019) 
787 0 |n https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2148 
787 0 |n https://doaj.org/toc/0030-9311 
787 0 |n https://doaj.org/toc/2338-476X 
856 4 1 |u https://doaj.org/article/9b0e4b59b8cf4fdc8072b908706c31db  |z Connect to this object online.